Dyne Therapeutics, Inc. DYN Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

Ionis PharmaceuticalsIONS

$13.02B+91.2%

Arrowhead ResearchARWR

$8.7B+418%

Wave Life SciencesWVE

$793.44M-9.4%

Solid Biosciences Inc.SLDB

$844.27M+224%

Edgewise Therapeutics, Inc.EWTX

$3.35B+63.5%

FAQ

What is Dyne Therapeutics, Inc.'s enterprise value?

Dyne Therapeutics, Inc. (DYN) reported enterprise value of $2.41B in Q1 2026.

How has Dyne Therapeutics, Inc.'s enterprise value changed year-over-year?

Dyne Therapeutics, Inc.'s enterprise value increased by 227.9% year-over-year, from $734.32M to $2.41B.

What is the long-term trend for Dyne Therapeutics, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s enterprise value has grown at a 27.6% compound annual growth rate (CAGR), from $738.87M to $2.5B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.